Home/Simphotek/Mary Potasek

MP

Mary Potasek

Co-founder and Chief Scientific Officer (CSO)

Therapeutic Areas

Simphotek Pipeline

Drug	Indication	Phase
Dosie™ for I-PDT	Malignant Pleural Mesothelioma	Pre-clinical/Development

Leadership Team at Simphotek

Gene (Evgueni) Parilov

Co-founder and Chief Technology Officer (CTO)

Co-founder and Vice President of Technology

View full Simphotek profile